Share

|

|

|

Baricitinib disappoints in SLE-BRAVE trials

Baricitinib has achieved largely negative results in the SLE-BRAVE trials, published in The Lancet.

This independent news story was supported by an educational grant from L’Institut Servier, Suresnes, France.

Promising results for focused ultrasound ablation in Parkinson’s disease

Focused ultrasound ablation of the globus pallidus internus improved symptoms in a substantial proportion of people with Parkinson’s disease in a randomised trial, but it comes with side effects.

This independent news story was supported by an educational grant from L’Institut Servier, Suresnes, France.

LAMP2: Atropine eyedrops may reduce myopia incidence in children

Children using nightly atropine eyedrops have a significantly lower incidence of myopia during 2 years of use than those using placebo, show the findings of the LAMP2 randomised trial.

This independent news story was supported by an educational grant from L’Institut Servier, Suresnes, France.

Reflux symptoms predict interstitial lung disease progression in SSc

Post-hoc analysis of a randomised trial shows that the severity of reflux symptoms in patients with systemic sclerosis predicts radiographic progression of interstitial lung disease.

This independent news story was supported by an educational grant from L’Institut Servier, Suresnes, France.

Anthracycline heart failure risk quantified for breast cancer, lymphoma patients

Patients who receive an anthracycline during treatment for breast cancer or lymphoma are more than three times as likely to develop congestive heart failure than healthy individuals, indicates a case–control study published in JAMA Network Open.

This independent news story was supported by an educational grant from L’Institut Servier, Suresnes, France.